nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC22A5—Dactinomycin—germ cell cancer	0.512	0.825	CbGbCtD
Ceftazidime—SLC22A6—Methotrexate—germ cell cancer	0.109	0.175	CbGbCtD
Ceftazidime—Asterixis—Ifosfamide—germ cell cancer	0.0217	0.0643	CcSEcCtD
Ceftazidime—SLC15A2—choroid plexus—germ cell cancer	0.0143	0.413	CbGeAlD
Ceftazidime—Local reaction—Bleomycin—germ cell cancer	0.0062	0.0184	CcSEcCtD
Ceftazidime—Nephropathy—Ifosfamide—germ cell cancer	0.00616	0.0183	CcSEcCtD
Ceftazidime—Nephropathy toxic—Bleomycin—germ cell cancer	0.00598	0.0177	CcSEcCtD
Ceftazidime—Nephropathy toxic—Ifosfamide—germ cell cancer	0.00511	0.0151	CcSEcCtD
Ceftazidime—Nephropathy—Etoposide—germ cell cancer	0.00487	0.0144	CcSEcCtD
Ceftazidime—Nephropathy toxic—Cisplatin—germ cell cancer	0.00441	0.0131	CcSEcCtD
Ceftazidime—Reaction gastrointestinal—Methotrexate—germ cell cancer	0.00416	0.0123	CcSEcCtD
Ceftazidime—Nephropathy toxic—Etoposide—germ cell cancer	0.00404	0.012	CcSEcCtD
Ceftazidime—Cholestasis—Ifosfamide—germ cell cancer	0.00387	0.0115	CcSEcCtD
Ceftazidime—Phlebitis—Vinblastine—germ cell cancer	0.00343	0.0102	CcSEcCtD
Ceftazidime—Skin exfoliation—Bleomycin—germ cell cancer	0.00328	0.00972	CcSEcCtD
Ceftazidime—Inflammation—Ifosfamide—germ cell cancer	0.00303	0.00897	CcSEcCtD
Ceftazidime—Aplastic anaemia—Dactinomycin—germ cell cancer	0.00301	0.00891	CcSEcCtD
Ceftazidime—Nephropathy—Methotrexate—germ cell cancer	0.00292	0.00864	CcSEcCtD
Ceftazidime—Phlebitis—Bleomycin—germ cell cancer	0.00289	0.00858	CcSEcCtD
Ceftazidime—Colitis—Ifosfamide—germ cell cancer	0.00282	0.00835	CcSEcCtD
Ceftazidime—Skin exfoliation—Ifosfamide—germ cell cancer	0.0028	0.00831	CcSEcCtD
Ceftazidime—Phlebitis—Dactinomycin—germ cell cancer	0.0027	0.008	CcSEcCtD
Ceftazidime—Coma—Ifosfamide—germ cell cancer	0.00268	0.00795	CcSEcCtD
Ceftazidime—Phlebitis—Ifosfamide—germ cell cancer	0.00247	0.00733	CcSEcCtD
Ceftazidime—Thrombophlebitis—Ifosfamide—germ cell cancer	0.00246	0.00729	CcSEcCtD
Ceftazidime—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00244	0.00723	CcSEcCtD
Ceftazidime—Pancytopenia—Vinblastine—germ cell cancer	0.00242	0.00718	CcSEcCtD
Ceftazidime—Skin exfoliation—Cisplatin—germ cell cancer	0.00242	0.00716	CcSEcCtD
Ceftazidime—Inflammation—Etoposide—germ cell cancer	0.00239	0.00708	CcSEcCtD
Ceftazidime—Lethargy—Dactinomycin—germ cell cancer	0.00237	0.00703	CcSEcCtD
Ceftazidime—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00236	0.00699	CcSEcCtD
Ceftazidime—Renal impairment—Ifosfamide—germ cell cancer	0.00224	0.00664	CcSEcCtD
Ceftazidime—Candida infection—Etoposide—germ cell cancer	0.00221	0.00656	CcSEcCtD
Ceftazidime—Skin exfoliation—Etoposide—germ cell cancer	0.00221	0.00656	CcSEcCtD
Ceftazidime—Encephalopathy—Methotrexate—germ cell cancer	0.00216	0.00641	CcSEcCtD
Ceftazidime—Phlebitis—Cisplatin—germ cell cancer	0.00213	0.00632	CcSEcCtD
Ceftazidime—Agranulocytosis—Vinblastine—germ cell cancer	0.00212	0.00629	CcSEcCtD
Ceftazidime—Bronchospasm—Bleomycin—germ cell cancer	0.00212	0.00628	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00209	0.00621	CcSEcCtD
Ceftazidime—Haemoglobin—Vinblastine—germ cell cancer	0.00205	0.00608	CcSEcCtD
Ceftazidime—Pancytopenia—Bleomycin—germ cell cancer	0.00205	0.00606	CcSEcCtD
Ceftazidime—Haemorrhage—Vinblastine—germ cell cancer	0.00204	0.00605	CcSEcCtD
Ceftazidime—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00203	0.00603	CcSEcCtD
Ceftazidime—Phlebitis—Etoposide—germ cell cancer	0.00195	0.00579	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00192	0.00569	CcSEcCtD
Ceftazidime—Pancytopenia—Dactinomycin—germ cell cancer	0.00191	0.00566	CcSEcCtD
Ceftazidime—Neutropenia—Dactinomycin—germ cell cancer	0.00188	0.00557	CcSEcCtD
Ceftazidime—Bronchospasm—Ifosfamide—germ cell cancer	0.00181	0.00537	CcSEcCtD
Ceftazidime—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.0018	0.266	CbGpPWpGaD
Ceftazidime—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00178	0.00526	CcSEcCtD
Ceftazidime—Pancytopenia—Ifosfamide—germ cell cancer	0.00175	0.00518	CcSEcCtD
Ceftazidime—Haemoglobin—Bleomycin—germ cell cancer	0.00173	0.00514	CcSEcCtD
Ceftazidime—Haemorrhage—Bleomycin—germ cell cancer	0.00172	0.00511	CcSEcCtD
Ceftazidime—Agranulocytosis—Dactinomycin—germ cell cancer	0.00167	0.00496	CcSEcCtD
Ceftazidime—Infestation—Ifosfamide—germ cell cancer	0.00164	0.00487	CcSEcCtD
Ceftazidime—Infestation NOS—Ifosfamide—germ cell cancer	0.00164	0.00487	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00163	0.00482	CcSEcCtD
Ceftazidime—Renal failure—Ifosfamide—germ cell cancer	0.00161	0.00478	CcSEcCtD
Ceftazidime—Flushing—Bleomycin—germ cell cancer	0.0016	0.00474	CcSEcCtD
Ceftazidime—Leukopenia—Vinblastine—germ cell cancer	0.00159	0.00472	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00155	0.0046	CcSEcCtD
Ceftazidime—Convulsion—Vinblastine—germ cell cancer	0.00154	0.00456	CcSEcCtD
Ceftazidime—Agranulocytosis—Ifosfamide—germ cell cancer	0.00153	0.00454	CcSEcCtD
Ceftazidime—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.00153	0.00453	CcSEcCtD
Ceftazidime—Erythema multiforme—Dactinomycin—germ cell cancer	0.00152	0.00451	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00152	0.00449	CcSEcCtD
Ceftazidime—Pancytopenia—Cisplatin—germ cell cancer	0.00151	0.00447	CcSEcCtD
Ceftazidime—Flushing—Dactinomycin—germ cell cancer	0.00149	0.00442	CcSEcCtD
Ceftazidime—Haemoglobin—Ifosfamide—germ cell cancer	0.00148	0.00439	CcSEcCtD
Ceftazidime—Haemorrhage—Ifosfamide—germ cell cancer	0.00147	0.00437	CcSEcCtD
Ceftazidime—Hallucination—Ifosfamide—germ cell cancer	0.00147	0.00435	CcSEcCtD
Ceftazidime—Inflammation—Methotrexate—germ cell cancer	0.00143	0.00424	CcSEcCtD
Ceftazidime—Bronchospasm—Etoposide—germ cell cancer	0.00143	0.00424	CcSEcCtD
Ceftazidime—Thrombocytopenia—Vinblastine—germ cell cancer	0.00142	0.00421	CcSEcCtD
Ceftazidime—Erythema multiforme—Ifosfamide—germ cell cancer	0.00139	0.00413	CcSEcCtD
Ceftazidime—Renal failure—Cisplatin—germ cell cancer	0.00139	0.00412	CcSEcCtD
Ceftazidime—Vaginal inflammation—Methotrexate—germ cell cancer	0.00139	0.00412	CcSEcCtD
Ceftazidime—Pancytopenia—Etoposide—germ cell cancer	0.00138	0.00409	CcSEcCtD
Ceftazidime—Flushing—Ifosfamide—germ cell cancer	0.00137	0.00405	CcSEcCtD
Ceftazidime—Neutropenia—Etoposide—germ cell cancer	0.00136	0.00403	CcSEcCtD
Ceftazidime—Leukopenia—Bleomycin—germ cell cancer	0.00134	0.00398	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00134	0.00397	CcSEcCtD
Ceftazidime—Angiopathy—Ifosfamide—germ cell cancer	0.00134	0.00396	CcSEcCtD
Ceftazidime—Immune system disorder—Ifosfamide—germ cell cancer	0.00133	0.00395	CcSEcCtD
Ceftazidime—Skin exfoliation—Methotrexate—germ cell cancer	0.00133	0.00393	CcSEcCtD
Ceftazidime—Vaginal infection—Methotrexate—germ cell cancer	0.00131	0.00389	CcSEcCtD
Ceftazidime—Aplastic anaemia—Methotrexate—germ cell cancer	0.0013	0.00386	CcSEcCtD
Ceftazidime—Paraesthesia—Vinblastine—germ cell cancer	0.0013	0.00386	CcSEcCtD
Ceftazidime—Infestation—Etoposide—germ cell cancer	0.0013	0.00384	CcSEcCtD
Ceftazidime—Infestation NOS—Etoposide—germ cell cancer	0.0013	0.00384	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00129	0.00381	CcSEcCtD
Ceftazidime—Renal failure—Etoposide—germ cell cancer	0.00127	0.00378	CcSEcCtD
Ceftazidime—Coma—Methotrexate—germ cell cancer	0.00127	0.00376	CcSEcCtD
Ceftazidime—Jaundice—Etoposide—germ cell cancer	0.00126	0.00375	CcSEcCtD
Ceftazidime—Leukopenia—Dactinomycin—germ cell cancer	0.00125	0.00371	CcSEcCtD
Ceftazidime—Pain—Vinblastine—germ cell cancer	0.00124	0.00368	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Etoposide—germ cell cancer	0.00123	0.00363	CcSEcCtD
Ceftazidime—Anaphylactic shock—Bleomycin—germ cell cancer	0.00123	0.00363	CcSEcCtD
Ceftazidime—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00122	0.181	CbGpPWpGaD
Ceftazidime—Agranulocytosis—Etoposide—germ cell cancer	0.00121	0.00359	CcSEcCtD
Ceftazidime—Vision blurred—Ifosfamide—germ cell cancer	0.00121	0.00358	CcSEcCtD
Ceftazidime—Thrombocytopenia—Bleomycin—germ cell cancer	0.0012	0.00356	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00119	0.00352	CcSEcCtD
Ceftazidime—Flushing—Cisplatin—germ cell cancer	0.00118	0.0035	CcSEcCtD
Ceftazidime—Agitation—Ifosfamide—germ cell cancer	0.00118	0.00349	CcSEcCtD
Ceftazidime—Angioedema—Ifosfamide—germ cell cancer	0.00117	0.00347	CcSEcCtD
Ceftazidime—Thrombophlebitis—Methotrexate—germ cell cancer	0.00116	0.00345	CcSEcCtD
Ceftazidime—Leukopenia—Ifosfamide—germ cell cancer	0.00115	0.0034	CcSEcCtD
Ceftazidime—Immune system disorder—Cisplatin—germ cell cancer	0.00115	0.0034	CcSEcCtD
Ceftazidime—Abdominal pain—Vinblastine—germ cell cancer	0.00115	0.0034	CcSEcCtD
Ceftazidime—Hypotension—Bleomycin—germ cell cancer	0.00114	0.00339	CcSEcCtD
Ceftazidime—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00112	0.00332	CcSEcCtD
Ceftazidime—SLC22A5—trigeminal ganglion—germ cell cancer	0.00111	0.0322	CbGeAlD
Ceftazidime—Convulsion—Ifosfamide—germ cell cancer	0.00111	0.00329	CcSEcCtD
Ceftazidime—Erythema multiforme—Etoposide—germ cell cancer	0.0011	0.00326	CcSEcCtD
Ceftazidime—Paraesthesia—Bleomycin—germ cell cancer	0.0011	0.00326	CcSEcCtD
Ceftazidime—SLC15A2—retina—germ cell cancer	0.00109	0.0316	CbGeAlD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00108	0.00322	CcSEcCtD
Ceftazidime—Flushing—Etoposide—germ cell cancer	0.00108	0.0032	CcSEcCtD
Ceftazidime—Hypersensitivity—Vinblastine—germ cell cancer	0.00107	0.00317	CcSEcCtD
Ceftazidime—Angiopathy—Etoposide—germ cell cancer	0.00106	0.00313	CcSEcCtD
Ceftazidime—Immune system disorder—Etoposide—germ cell cancer	0.00105	0.00312	CcSEcCtD
Ceftazidime—Pain—Bleomycin—germ cell cancer	0.00105	0.00311	CcSEcCtD
Ceftazidime—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00105	0.0031	CcSEcCtD
Ceftazidime—Vision blurred—Cisplatin—germ cell cancer	0.00104	0.00309	CcSEcCtD
Ceftazidime—Tremor—Cisplatin—germ cell cancer	0.00104	0.00307	CcSEcCtD
Ceftazidime—Lethargy—Methotrexate—germ cell cancer	0.00103	0.00305	CcSEcCtD
Ceftazidime—Nervous system disorder—Ifosfamide—germ cell cancer	0.00103	0.00304	CcSEcCtD
Ceftazidime—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00103	0.00304	CcSEcCtD
Ceftazidime—Skin disorder—Ifosfamide—germ cell cancer	0.00102	0.00301	CcSEcCtD
Ceftazidime—SLC15A1—endocrine gland—germ cell cancer	0.00101	0.0293	CbGeAlD
Ceftazidime—SLC15A2—telencephalon—germ cell cancer	0.001	0.0291	CbGeAlD
Ceftazidime—Diarrhoea—Vinblastine—germ cell cancer	0.000993	0.00294	CcSEcCtD
Ceftazidime—Dysgeusia—Etoposide—germ cell cancer	0.000992	0.00294	CcSEcCtD
Ceftazidime—Leukopenia—Cisplatin—germ cell cancer	0.00099	0.00293	CcSEcCtD
Ceftazidime—Hypotension—Ifosfamide—germ cell cancer	0.000979	0.0029	CcSEcCtD
Ceftazidime—Pain—Dactinomycin—germ cell cancer	0.000977	0.0029	CcSEcCtD
Ceftazidime—Urticaria—Bleomycin—germ cell cancer	0.000973	0.00288	CcSEcCtD
Ceftazidime—Body temperature increased—Bleomycin—germ cell cancer	0.000969	0.00287	CcSEcCtD
Ceftazidime—Dizziness—Vinblastine—germ cell cancer	0.000959	0.00284	CcSEcCtD
Ceftazidime—Convulsion—Cisplatin—germ cell cancer	0.000958	0.00284	CcSEcCtD
Ceftazidime—SLC22A5—retina—germ cell cancer	0.00095	0.0275	CbGeAlD
Ceftazidime—Paraesthesia—Ifosfamide—germ cell cancer	0.00094	0.00279	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000935	0.00277	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000934	0.00277	CcSEcCtD
Ceftazidime—Vomiting—Vinblastine—germ cell cancer	0.000922	0.00273	CcSEcCtD
Ceftazidime—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00092	0.136	CbGpPWpGaD
Ceftazidime—Headache—Vinblastine—germ cell cancer	0.000909	0.00269	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000908	0.00269	CcSEcCtD
Ceftazidime—Leukopenia—Etoposide—germ cell cancer	0.000907	0.00269	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000904	0.00268	CcSEcCtD
Ceftazidime—Body temperature increased—Dactinomycin—germ cell cancer	0.000903	0.00268	CcSEcCtD
Ceftazidime—Abdominal pain—Dactinomycin—germ cell cancer	0.000903	0.00268	CcSEcCtD
Ceftazidime—Anaphylactic shock—Cisplatin—germ cell cancer	0.000903	0.00268	CcSEcCtD
Ceftazidime—Hypersensitivity—Bleomycin—germ cell cancer	0.000903	0.00268	CcSEcCtD
Ceftazidime—Pain—Ifosfamide—germ cell cancer	0.000896	0.00265	CcSEcCtD
Ceftazidime—Nervous system disorder—Cisplatin—germ cell cancer	0.000885	0.00262	CcSEcCtD
Ceftazidime—Thrombocytopenia—Cisplatin—germ cell cancer	0.000884	0.00262	CcSEcCtD
Ceftazidime—Convulsion—Etoposide—germ cell cancer	0.000878	0.0026	CcSEcCtD
Ceftazidime—Skin disorder—Cisplatin—germ cell cancer	0.000877	0.0026	CcSEcCtD
Ceftazidime—SLC22A6—brain—germ cell cancer	0.000871	0.0252	CbGeAlD
Ceftazidime—Pruritus—Bleomycin—germ cell cancer	0.000867	0.00257	CcSEcCtD
Ceftazidime—Eosinophilia—Methotrexate—germ cell cancer	0.000863	0.00256	CcSEcCtD
Ceftazidime—Nausea—Vinblastine—germ cell cancer	0.000862	0.00255	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000857	0.00254	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000856	0.00254	CcSEcCtD
Ceftazidime—Hypotension—Cisplatin—germ cell cancer	0.000844	0.0025	CcSEcCtD
Ceftazidime—Hypersensitivity—Dactinomycin—germ cell cancer	0.000842	0.0025	CcSEcCtD
Ceftazidime—SLC22A5—skin of body—germ cell cancer	0.000834	0.0241	CbGeAlD
Ceftazidime—Urticaria—Ifosfamide—germ cell cancer	0.000832	0.00247	CcSEcCtD
Ceftazidime—Abdominal pain—Ifosfamide—germ cell cancer	0.000828	0.00245	CcSEcCtD
Ceftazidime—Body temperature increased—Ifosfamide—germ cell cancer	0.000828	0.00245	CcSEcCtD
Ceftazidime—Pancytopenia—Methotrexate—germ cell cancer	0.000827	0.00245	CcSEcCtD
Ceftazidime—Anaphylactic shock—Etoposide—germ cell cancer	0.000827	0.00245	CcSEcCtD
Ceftazidime—SLC15A2—pituitary gland—germ cell cancer	0.000818	0.0237	CbGeAlD
Ceftazidime—Neutropenia—Methotrexate—germ cell cancer	0.000815	0.00241	CcSEcCtD
Ceftazidime—Paraesthesia—Cisplatin—germ cell cancer	0.000811	0.0024	CcSEcCtD
Ceftazidime—Thrombocytopenia—Etoposide—germ cell cancer	0.00081	0.0024	CcSEcCtD
Ceftazidime—Skin disorder—Etoposide—germ cell cancer	0.000803	0.00238	CcSEcCtD
Ceftazidime—SLC15A2—medulla oblongata—germ cell cancer	0.000789	0.0228	CbGeAlD
Ceftazidime—Diarrhoea—Dactinomycin—germ cell cancer	0.000782	0.00232	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000779	0.00231	CcSEcCtD
Ceftazidime—Vomiting—Bleomycin—germ cell cancer	0.000779	0.00231	CcSEcCtD
Ceftazidime—Infestation NOS—Methotrexate—germ cell cancer	0.000777	0.0023	CcSEcCtD
Ceftazidime—Infestation—Methotrexate—germ cell cancer	0.000777	0.0023	CcSEcCtD
Ceftazidime—Hypotension—Etoposide—germ cell cancer	0.000773	0.00229	CcSEcCtD
Ceftazidime—Rash—Bleomycin—germ cell cancer	0.000773	0.00229	CcSEcCtD
Ceftazidime—Pain—Cisplatin—germ cell cancer	0.000772	0.00229	CcSEcCtD
Ceftazidime—Dermatitis—Bleomycin—germ cell cancer	0.000772	0.00229	CcSEcCtD
Ceftazidime—Hypersensitivity—Ifosfamide—germ cell cancer	0.000772	0.00229	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00077	0.00228	CcSEcCtD
Ceftazidime—Renal failure—Methotrexate—germ cell cancer	0.000764	0.00226	CcSEcCtD
Ceftazidime—Paraesthesia—Etoposide—germ cell cancer	0.000743	0.0022	CcSEcCtD
Ceftazidime—Pruritus—Ifosfamide—germ cell cancer	0.000741	0.0022	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000735	0.00218	CcSEcCtD
Ceftazidime—SLC15A2—adrenal gland—germ cell cancer	0.000731	0.0211	CbGeAlD
Ceftazidime—Nausea—Bleomycin—germ cell cancer	0.000728	0.00216	CcSEcCtD
Ceftazidime—Vomiting—Dactinomycin—germ cell cancer	0.000727	0.00215	CcSEcCtD
Ceftazidime—Agranulocytosis—Methotrexate—germ cell cancer	0.000725	0.00215	CcSEcCtD
Ceftazidime—SLC15A2—midbrain—germ cell cancer	0.000721	0.0209	CbGeAlD
Ceftazidime—Rash—Dactinomycin—germ cell cancer	0.000721	0.00214	CcSEcCtD
Ceftazidime—Diarrhoea—Ifosfamide—germ cell cancer	0.000717	0.00212	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000714	0.00212	CcSEcCtD
Ceftazidime—Body temperature increased—Cisplatin—germ cell cancer	0.000714	0.00212	CcSEcCtD
Ceftazidime—SLC22A5—pituitary gland—germ cell cancer	0.000711	0.0206	CbGeAlD
Ceftazidime—Pain—Etoposide—germ cell cancer	0.000707	0.0021	CcSEcCtD
Ceftazidime—SLC15A2—spinal cord—germ cell cancer	0.000704	0.0204	CbGeAlD
Ceftazidime—Haemoglobin—Methotrexate—germ cell cancer	0.000701	0.00208	CcSEcCtD
Ceftazidime—Haemorrhage—Methotrexate—germ cell cancer	0.000697	0.00207	CcSEcCtD
Ceftazidime—Dizziness—Ifosfamide—germ cell cancer	0.000692	0.00205	CcSEcCtD
Ceftazidime—SLC22A5—medulla oblongata—germ cell cancer	0.000686	0.0199	CbGeAlD
Ceftazidime—SLC15A2—female gonad—germ cell cancer	0.000681	0.0197	CbGeAlD
Ceftazidime—Nausea—Dactinomycin—germ cell cancer	0.000679	0.00201	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Etoposide—germ cell cancer	0.000676	0.002	CcSEcCtD
Ceftazidime—Vomiting—Ifosfamide—germ cell cancer	0.000666	0.00197	CcSEcCtD
Ceftazidime—Hypersensitivity—Cisplatin—germ cell cancer	0.000665	0.00197	CcSEcCtD
Ceftazidime—Rash—Ifosfamide—germ cell cancer	0.00066	0.00196	CcSEcCtD
Ceftazidime—Dermatitis—Ifosfamide—germ cell cancer	0.00066	0.00196	CcSEcCtD
Ceftazidime—Erythema multiforme—Methotrexate—germ cell cancer	0.000659	0.00195	CcSEcCtD
Ceftazidime—Urticaria—Etoposide—germ cell cancer	0.000657	0.00195	CcSEcCtD
Ceftazidime—Abdominal pain—Etoposide—germ cell cancer	0.000654	0.00194	CcSEcCtD
Ceftazidime—Body temperature increased—Etoposide—germ cell cancer	0.000654	0.00194	CcSEcCtD
Ceftazidime—SLC22A5—adrenal gland—germ cell cancer	0.000635	0.0184	CbGeAlD
Ceftazidime—SLC15A2—endocrine gland—germ cell cancer	0.000634	0.0183	CbGeAlD
Ceftazidime—Angiopathy—Methotrexate—germ cell cancer	0.000633	0.00188	CcSEcCtD
Ceftazidime—Immune system disorder—Methotrexate—germ cell cancer	0.00063	0.00187	CcSEcCtD
Ceftazidime—SLC22A5—midbrain—germ cell cancer	0.000627	0.0182	CbGeAlD
Ceftazidime—SLC15A2—head—germ cell cancer	0.000625	0.0181	CbGeAlD
Ceftazidime—Nausea—Ifosfamide—germ cell cancer	0.000622	0.00184	CcSEcCtD
Ceftazidime—Diarrhoea—Cisplatin—germ cell cancer	0.000618	0.00183	CcSEcCtD
Ceftazidime—SLC22A5—spinal cord—germ cell cancer	0.000612	0.0177	CbGeAlD
Ceftazidime—Hypersensitivity—Etoposide—germ cell cancer	0.000609	0.00181	CcSEcCtD
Ceftazidime—SLC15A2—testis—germ cell cancer	0.000604	0.0175	CbGeAlD
Ceftazidime—Dysgeusia—Methotrexate—germ cell cancer	0.000594	0.00176	CcSEcCtD
Ceftazidime—SLC22A5—female gonad—germ cell cancer	0.000592	0.0171	CbGeAlD
Ceftazidime—Pruritus—Etoposide—germ cell cancer	0.000585	0.00173	CcSEcCtD
Ceftazidime—Vomiting—Cisplatin—germ cell cancer	0.000574	0.0017	CcSEcCtD
Ceftazidime—Vision blurred—Methotrexate—germ cell cancer	0.000572	0.0017	CcSEcCtD
Ceftazidime—Rash—Cisplatin—germ cell cancer	0.000569	0.00169	CcSEcCtD
Ceftazidime—Dermatitis—Cisplatin—germ cell cancer	0.000569	0.00169	CcSEcCtD
Ceftazidime—Diarrhoea—Etoposide—germ cell cancer	0.000566	0.00168	CcSEcCtD
Ceftazidime—SLC15A2—cerebellum—germ cell cancer	0.000558	0.0161	CbGeAlD
Ceftazidime—Dizziness—Etoposide—germ cell cancer	0.000547	0.00162	CcSEcCtD
Ceftazidime—Leukopenia—Methotrexate—germ cell cancer	0.000543	0.00161	CcSEcCtD
Ceftazidime—Nausea—Cisplatin—germ cell cancer	0.000536	0.00159	CcSEcCtD
Ceftazidime—Convulsion—Methotrexate—germ cell cancer	0.000526	0.00156	CcSEcCtD
Ceftazidime—Vomiting—Etoposide—germ cell cancer	0.000526	0.00156	CcSEcCtD
Ceftazidime—SLC22A5—testis—germ cell cancer	0.000525	0.0152	CbGeAlD
Ceftazidime—Rash—Etoposide—germ cell cancer	0.000521	0.00155	CcSEcCtD
Ceftazidime—Dermatitis—Etoposide—germ cell cancer	0.000521	0.00154	CcSEcCtD
Ceftazidime—Headache—Etoposide—germ cell cancer	0.000518	0.00154	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000513	0.00152	CcSEcCtD
Ceftazidime—Anaphylactic shock—Methotrexate—germ cell cancer	0.000495	0.00147	CcSEcCtD
Ceftazidime—Nausea—Etoposide—germ cell cancer	0.000491	0.00146	CcSEcCtD
Ceftazidime—Nervous system disorder—Methotrexate—germ cell cancer	0.000486	0.00144	CcSEcCtD
Ceftazidime—SLC22A5—cerebellum—germ cell cancer	0.000485	0.014	CbGeAlD
Ceftazidime—Thrombocytopenia—Methotrexate—germ cell cancer	0.000485	0.00144	CcSEcCtD
Ceftazidime—Skin disorder—Methotrexate—germ cell cancer	0.000481	0.00143	CcSEcCtD
Ceftazidime—Hypotension—Methotrexate—germ cell cancer	0.000463	0.00137	CcSEcCtD
Ceftazidime—SLC15A2—brain—germ cell cancer	0.000453	0.0131	CbGeAlD
Ceftazidime—Paraesthesia—Methotrexate—germ cell cancer	0.000445	0.00132	CcSEcCtD
Ceftazidime—SLC15A2—lymph node—germ cell cancer	0.000438	0.0127	CbGeAlD
Ceftazidime—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000428	0.00127	CcSEcCtD
Ceftazidime—Pain—Methotrexate—germ cell cancer	0.000424	0.00126	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000405	0.0012	CcSEcCtD
Ceftazidime—SLC22A5—brain—germ cell cancer	0.000394	0.0114	CbGeAlD
Ceftazidime—Urticaria—Methotrexate—germ cell cancer	0.000394	0.00117	CcSEcCtD
Ceftazidime—Abdominal pain—Methotrexate—germ cell cancer	0.000392	0.00116	CcSEcCtD
Ceftazidime—Body temperature increased—Methotrexate—germ cell cancer	0.000392	0.00116	CcSEcCtD
Ceftazidime—SLC22A5—lymph node—germ cell cancer	0.000381	0.011	CbGeAlD
Ceftazidime—Hypersensitivity—Methotrexate—germ cell cancer	0.000365	0.00108	CcSEcCtD
Ceftazidime—Pruritus—Methotrexate—germ cell cancer	0.000351	0.00104	CcSEcCtD
Ceftazidime—Diarrhoea—Methotrexate—germ cell cancer	0.000339	0.001	CcSEcCtD
Ceftazidime—Dizziness—Methotrexate—germ cell cancer	0.000328	0.000971	CcSEcCtD
Ceftazidime—Vomiting—Methotrexate—germ cell cancer	0.000315	0.000934	CcSEcCtD
Ceftazidime—Rash—Methotrexate—germ cell cancer	0.000312	0.000926	CcSEcCtD
Ceftazidime—Dermatitis—Methotrexate—germ cell cancer	0.000312	0.000925	CcSEcCtD
Ceftazidime—Headache—Methotrexate—germ cell cancer	0.00031	0.00092	CcSEcCtD
Ceftazidime—Nausea—Methotrexate—germ cell cancer	0.000294	0.000872	CcSEcCtD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000248	0.0367	CbGpPWpGaD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000244	0.0362	CbGpPWpGaD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000187	0.0277	CbGpPWpGaD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000184	0.0273	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000123	0.0183	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000122	0.018	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000115	0.017	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000113	0.0167	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000113	0.0167	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000111	0.0164	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.59e-05	0.0142	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.9e-05	0.0132	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.75e-05	0.013	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	8.5e-05	0.0126	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	8.38e-05	0.0124	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.61e-05	0.00979	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.27e-05	0.0093	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.18e-05	0.00916	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.82e-05	0.00863	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.73e-05	0.0085	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.73e-05	0.00849	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.69e-05	0.00844	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.64e-05	0.00836	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.28e-05	0.00783	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.2e-05	0.0077	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.32e-05	0.0064	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.26e-05	0.00631	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.92e-05	0.00581	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.89e-05	0.00429	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.69e-05	0.00398	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	2.64e-05	0.00391	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	1.99e-05	0.00295	CbGpPWpGaD
